Page last updated: 2024-10-29
ifosfamide and B-Cell Leukemia
ifosfamide has been researched along with B-Cell Leukemia in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Griffin, TC | 1 |
Weitzman, S | 1 |
Weinstein, H | 1 |
Chang, M | 1 |
Cairo, M | 1 |
Hutchison, R | 1 |
Shiramizu, B | 1 |
Wiley, J | 1 |
Woods, D | 1 |
Barnich, M | 1 |
Gross, TG | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia[NCT01429610] | Phase 2 | 78 participants (Actual) | Interventional | 2011-11-30 | Active, not recruiting |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for ifosfamide and B-Cell Leukemia